Portfolio Archives - Page 2 of 2

New Innovative Cancer Technology Wins 2023 Falcons’ Fortunes Pitch Competition

Posted on March 31, 2023 (September 25, 2023) by nicole

March 31, 2023 – The winning pitch for the 10th anniversary Falcons’ Fortunes pitch competition and the $100,000 Ernsting Entrepreneurship Award was delivered by Dr. Sumaiyah Rehman, co-founder and CEO of DTPx Therapeutics.

FACIT’s Prospects Fund invests in two emerging Ontario diagnostics for colorectal and prostate cancers

Posted on September 16, 2021 (September 13, 2024) by jeremy

September 16, 2021 – September 16, 2021 – Both innovations were previous finalists in FACIT’s 2021 Falcons’ Fortunes pitch competition.

FACIT leads seed round in Nanology Labs

Posted on May 18, 2021 (July 4, 2024) by jeremy

May 18, 2021 – May 18, 2021 – FACIT deploys Ontario First capital, enables rising local start-up to reach critical value inflection point. FACIT has previously supported Nanology, spun out of the University of Toronto, through both its early-stage Prospects Oncology Fund and seed-stage Compass Rose Oncology Fund.

FACIT crowns 2021 winner of Falcons’ Fortunes pitch competition; announces follow-on investment in 2020 winner, Bridge7 Oncology

Posted on February 4, 2021 (July 4, 2024) by jeremy

February 4, 2021 – February 4, 2021 – FACIT’s Prospects Oncology Fund and its annual pitch competition help to advance Ontario oncology innovations.

FACIT fuels promising made-in-Ontario breast cancer therapeutic and medtech innovations through Prospects Oncology Fund

Posted on December 10, 2020 (July 4, 2024) by jeremy

December 10, 2020 – December 10, 2020 – The newest recipients of Ontario First seed capital include Dr. Rebecca Laposa of the University of Toronto, as well as London-based start-up Multi-Magnetics Inc.

FACIT Announces Artificial Intelligence pitch as Winner of 2020 Falcons’ Fortunes on World Cancer Day

Posted on February 5, 2020 (July 4, 2024) by jeremy

February 5, 2020 – February 5, 2020 – The winning pitch was delivered by Mr. Meir Dick of Bridge7 Oncology. This local start-up is scaling clinical expertise with AI to automate and improve the efficiency, consistency and quality of delivering cancer care.

FACIT announces follow-on investments in Xpan Inc. and Nanology Labs through Compass Rose Fund

Posted on January 28, 2020 (July 4, 2024) by jeremy

January 28, 2020 – January 28, 2020 – Spun out of the University of Toronto, both start-ups have previously received funding through FACIT’s proof-of-concept Prospects Fund.

FACIT Announces Investment in 3 Ontario Start-ups Under Prospects Fund

Posted on July 10, 2017 (October 11, 2024) by jeremy

July 10, 2017 – Ontario start-ups Radialis Medical of Thunder Bay, KA Imaging of Kitchener, and DNAstack of Toronto are the first to receive capital from FACIT’s new Prospects Oncology Fund for proof-of-concept development of breakthrough cancer technologies.